Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03320512
Other study ID # 17-1951
Secondary ID 5U19HD089881-02
Status Completed
Phase N/A
First received
Last updated
Start date May 15, 2019
Est. completion date September 16, 2021

Study information

Verified date August 2022
Source University of North Carolina, Chapel Hill
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

P3 (Prepared, Protected, emPowered) is an interactive smartphone app for HIV-uninfected YMSM and YTW that utilizes social networking and game-based mechanics as well as a comprehensive understanding of what constitutes "best practices" in app development to improve PrEP adherence and persistence in PrEP care.


Description:

Sustainable, integrated PrEP adherence interventions are critically needed to reduce HIV incidence among YMSM and YTW. It is imperative that the investigators develop adherence interventions for YMSM and YTW initiating PrEP that are engaging, age-appropriate and take advantage of technologies that are already embedded in these individual's lives. A smartphone-delivered PrEP adherence intervention is well suited for this population, given they have a high-uptake and utilization of smartphone technology. The use of smartphones to deliver HIV prevention and care interventions has grown substantially in recent years due to: a) wide-scale adoption of smartphone technology among high-risk groups, b) the ability to deliver interventions in real-time within risk contexts, and c) low implementation costs.The accessibility, affordability, anonymity and acceptability of smartphones make them the intervention medium of choice for engaging youth and a logical platform to deliver an adherence intervention targeting PrEP. Further, smartphone interventions address can overcome issues that impede engagement with in-person interventions such as transportation logistics, stigma and confidentiality. Further youth, including YMSM and YTW are receptive to smartphone delivered interventions and these interventions can impact HIV related prevention behaviors. P3 (Prepared, Protected, emPowered) is an interactive smartphone app for HIV-uninfected YMSM and YTW that utilizes social networking and game-based mechanics as well as a comprehensive understanding of what constitutes "best practices" in app development to improve PrEP adherence and persistence in PrEP care. Built on a successful, evidence-based platform designed and tested by our collaborating technology partner, Ayogo, P3 is flexible and responsive to changes in technology. This flexibility will also allow us to quickly respond to and modify our intervention to align with emerging PrEP practice standards and guidelines. Despite the benefits of app-based interventions, maintaining engagement over time can be particularly challenging. Lack of rapport building may contribute to lower retention rates in technology-based interventions. Further, the available literature suggests that some tools, including technology based tools, may be more beneficial to patient adherence when combined with education or counseling. To investigate this possibility, the investigators will include a study arm (P3+) that includes P3 and adherence counseling delivered by a counselor through the P3 app. This study has three phases, usability testing, field testing, and a randomized-controlled trial (RCT). In usability testing the investigators will test beta versions of the app and gain feedback about the intervention from the target population, identify any technical issues, and get feedback on app content. Field testing is to ensure that the features, platform and content of P3 and P3+ are acceptable to the target population and that there are no technical challenges or user concerns with either the app, the dried blood spot (DBS), hair, or mitra sampling collection. The last phase is a three arm, RCT that will test the efficacy of P3, a novel, theory-based mobile app that utilizes game mechanics and social networking features to improve PrEP adherence, retention in PrEP clinical care, and PrEP persistence among young men who have sex with men (YMSM) and young trans women (YTW) who have sex with men, ages 16-24. The investigators will test the efficacy of P3 and P3+, which adds Next Step Counseling delivered by an adherence counselor through the app, against PrEP standard of care. Participants will be randomized to P3, P3+, or standard of care. A cost comparison between P3 and P3+ will be conducted.


Recruitment information / eligibility

Status Completed
Enrollment 246
Est. completion date September 16, 2021
Est. primary completion date September 16, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 16 Years to 24 Years
Eligibility Inclusion Criteria: - Are aged 16-24 - Were assigned male sex at birth - Report sex with men or transgender women - Are able to speak and read English - Have reliable daily access to an Android or iOS smartphone with a data plan - Are HIV-uninfected (self-report) - Are not currently on PrEP but plan to initiate in the next 7 days and have an active PrEP prescription (prescription confirmed by study staff) OR on PrEP have an active PrEP prescription (prescription confirmed by study staff) - Recruited from one of 9 subject recruitment venues (SRV) cities (Atlanta, Georgia; Boston, Massachusetts; Bronx, New York; Chicago, Illinois; Houston, Texas; Philadelphia, Pennsylvania; Tampa, Florida; Chapel Hill, NC; Charlotte, NC) Exclusion Criteria: - Aged younger than 15 years or older than 24 years - Not available to meet with project staff for planned study visit(s) - Non-English speaking - Living with HIV - Not currently prescribed PrEP (study staff unable to verify participant has an active PrEP prescription by a health provider) - Anticipate not having reliable access to a smartphone with a data plan for 2 or more days during field testing or 1 or more weeks during the RCT intervention period - Planning to move out of study area during the study period - Unwilling or unable to comply with protocol requirements. - Participated in field trial phase of P3 study - Unable to be consented due to active substance use or psychological condition.

Study Design


Intervention

Behavioral:
P3
P3 is an interactive smartphone app that utilizes social networking and game-based mechanics to improve PrEP adherence and persistence in PrEP care. The participant will install P3 on their phone, receive a guided tour of the app and a reminder card with the research coordinator's phone number and email address and instructed to contact the research coordinator immediately to report difficulties with any app components or to report any problems with their phone or phone service. A help link is embedded within the app that directly links to study staff if assistance is needed. P3 arm participants will have 24-hour access to all features of P3.
P3+
In P3+, participants receive all of P3 and the ability to text in the app with an adherence counselor, using Next Step Counseling (NSC). NSC is an interactive, client-centered motivational intervention to improve PrEP adherence. Key components of NSC include: review experiences with adherence, exploration of adherence facilitators and barriers, identification of adherence needs, identification of strategies to meet needs, and development of an adherence action plan. Participants will install P3+ on their phone. The adherence counselor feature will be unlocked for those in the P3+ arm. P3+ participants will have 24-hour access to all features of P3+.
Control
Control participants will receive the standard of care for receiving a prescription for PrEP.

Locations

Country Name City State
United States PRISM Health Atlanta Georgia
United States The Fenway Institute Boston Massachusetts
United States Children's Hospital at Montefiore Bronx New York
United States UNC-Chapel Hill Chapel Hill North Carolina
United States RAIN Charlotte North Carolina
United States The Adolescent and Young Adult Research (AYAR) at the CORE Center Chicago Illinois
United States Texas Children's Hospital Houston Texas
United States Adolescent Initiative at Children's Hospital of Philadelphia Philadelphia Pennsylvania
United States University of South Florida Infectious Diseases Tampa Florida

Sponsors (10)

Lead Sponsor Collaborator
University of North Carolina, Chapel Hill Baylor College of Medicine, Children's Hospital of Philadelphia, Duke University, Emory University, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Montefiore Hospital, Ruth M. Rothstein CORE Center, The Fenway Institute, University of South Florida

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary PrEP Adherence Defined by Tenofovir Diphosphate (P3 and P3+ vs Control) PrEP adherence is measured by blood sample levels of tenofovir diphosphate (TFV-DP) with blood concentration consistent with > 4 doses/week at 3- and 6- month follow-ups. The estimation of the average treatment effect compared P3 and P3+ combined to Control. Month 3, Month 6
Primary PrEP Adherence Defined by Emtricitabine Triphosphate (P3 and P3+ vs Control) PrEP adherence is measured by blood sample levels of emtricitabine triphosphate (FTC-TP) with blood concentration consistent with > 4 doses/week at 3- and 6- month follow-ups. The estimation of the average treatment effect compared P3 and P3+ combined to Control. Month 3, Month 6
Secondary Number of Participants With Self-reported Retention in PrEP Clinical Care The investigators define "retention in care" as at least 1 PrEP clinical visit occurring in the last 3 months. Month 3, Month 6
Secondary PrEP Persistence PrEP persistence will be measured by self-report at follow up of current PrEP use. Month 3, Month 6
Secondary Insertive Condomless Anal Sex Sexual Practices were assessed by self-reported number of insertive condomless anal sex occurrences during the past 3 months. This question is asked at the 3- and 6-month follow-up surveys. Month 3, Month 6
Secondary Receptive Condomless Anal Sex Sexual Practices were assessed by self-reported number of receptive condomless anal sex occurrences during the past 3 months. This question is asked at the 3- and 6-month follow-up surveys. Month 3, Month 6
Secondary Sexually Transmitted Infections (STI) Incidence Self-reported STIs (combined rectal and urethral gonorrhea and chlamydia, syphilis) in last 3 months. This question is asked at the 3- and 6-month follow-up surveys. Month 3, Month 6
Secondary PrEP Adherence Defined by Tenofovir Diphosphate (P3 vs Control and P3+ vs Control) PrEP adherence is measured by blood sample levels of tenofovir diphosphate (TFV-DP) with blood concentration consistent with > 4 doses/week at 3- and 6- month follow-ups. The estimation of the average treatment effect compared P3 to Control and also P3+ to Control. Month 3, Month 6
Secondary PrEP Adherence Defined by Emtricitabine Triphosphate (P3 vs Control and P3+ vs Control) PrEP adherence is measured by blood sample levels of emtricitabine triphosphate (FTC-TP) with blood concentration consistent with > 4 doses/week at 3- and 6- month follow-ups. The estimation of the average treatment effect compared P3 to Control and also P3+ to Control. Month 3, Month 6
Secondary Self-Reported Weekly PrEP Use Number of participants reported taking their PrEP medication >/= 4 days in the past week. Month 3, Month 6
Secondary Self-Reported Monthly PrEP Use Median self-reported percent of time in the past month that participants' took their PrEP as prescribed. Month 3, Month 6
Secondary Mean Site-Level Intervention Cost Information was collected on (1) time spent by study staff for training and supervision of adherence counselor(s); (2) time participants spent in the adherence counseling sessions; and (3) costs associated with the delivery of both P3 and P3+. Resources were organized into standard expenditure categories and attributed to the corresponding P3 or P3+ arm and study site as appropriate. Throughout the duration of the study, approximately 1.5 years
See also
  Status Clinical Trial Phase
Completed NCT02579135 - Reducing HIV Risk Among Adolescents: Evaluating Project HEART N/A
Enrolling by invitation NCT06127277 - Next4You: A Fully Mobile Relationships Based Program for Youth in Foster Care N/A
Recruiting NCT05889689 - Evaluation of an Adolescent Pregnancy Prevention Program; Relationship Smarts+ With Lessons From Mind Matters N/A
Completed NCT02516930 - A Non-inferiority Randomized Controlled Trial to Evaluate Promoting Condom Use Among MSM and Transgender Individuals in China N/A
Completed NCT03063385 - Puerto Rico Cuidalos Parent-adolescent Program N/A
Completed NCT01411878 - Louisville Teen Pregnancy Prevention Project N/A
Completed NCT02009046 - Randomized Evaluation of a Multi-Component, Rights-Based Sexuality Education Initiative for High School Students N/A
Completed NCT01303575 - Internet-Based Sexual Health Education for Middle School Native American Youth N/A
Completed NCT00167505 - All About Youth: Evaluation of Sexual Risk Avoidance and Risk Reduction Programs for Middle School Students N/A
Completed NCT00183456 - A Peer-Oriented HIV Prevention Outreach Program for Individuals at High Risk for HIV and Other STIs Phase 2
Completed NCT00336180 - Adolescent Drug and HIV Prevention in South Africa Phase 2/Phase 3
Completed NCT00710060 - Effectiveness of a Community-level HIV/STD Prevention Intervention in Promoting Safer Sexual Behaviors in High-risk Populations Phase 3
Completed NCT01084395 - Reducing HIV Risk Among Mexican Youth N/A
Completed NCT00161382 - Development and Evaluation of an HIV, STD, and Pregnancy Prevention Program for Middle School Students N/A
Completed NCT00640653 - Efficacy of an Abstinence-Only HIV Risk-Reduction Intervention for Young African-American Adolescents N/A
Completed NCT00289939 - Reducing HIV & Domestic Violence Risk in Women Offenders Phase 3
Completed NCT00137943 - Parents Matter!: Interventions to Promote Effective Parent-Child Communication Phase 1
Completed NCT03408743 - Engineering an Online STI Prevention Program: CSE2 N/A
Completed NCT06104813 - Evaluation of Deaf Men's Knowledge About Sexual Health
Not yet recruiting NCT05910580 - Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years N/A